GlassScriptPhysician profile
Scott M Fair
NPI 1700278710
$19,256.29
in general payments reported to CMS, 2019-2025
32 companies · $8,279 in 2025
The $8,279 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $595 · 2021: $1,280 · 2022: $1,349 · 2023: $5,891 · 2024: $1,161 · 2025: $8,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,250 · Food and Beverage: $5,049 · Travel and Lodging: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,250.00 |
| Food and Beverage | $5,048.99 |
| Travel and Lodging | $1,031.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $6,771.29 | 2022-2025 | Envista Mx60 Iol, Toric, Ic-8 Apthera Iol |
| Carl Zeiss Meditec Cataract Technology INC. | $3,702.55 | 2022-2023 | |
| Alcon Vision LLC | $2,800.68 | 2019-2025 | Clareon, Centurion, Argos |
| Abbvie INC. | $774.22 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $483.90 | 2021-2025 | Tecnis Iol, Veritas Vision System, Tecnis Iol |
| Rxsight INC | $415.68 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| New World Medical,INC. | $374.42 | 2022-2025 | Kahook Dual Blade, Via360, Clearpath |
| Alimera Sciences, INC. | $350.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $317.65 | 2019-2025 | Eylea, Eylea Hd |
| Sun Pharmaceutical Industries INC. | $316.78 | 2021-2025 | Cequa |
| Harrow Eye, LLC | $310.47 | 2024-2025 | Triesence, Vevye, Iheezo |
| Astellas Pharma US INC | $298.19 | 2023-2025 | Izervay |
| Allergan, INC. | $291.49 | 2020-2022 | |
| Glaukos Corporation | $242.92 | 2023-2025 | Idosetr, Istent Infinite, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Genentech USA, INC. | $237.98 | 2020-2025 | Vabysmo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $188.60 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $180.40 | 2023-2025 | Syfovre |
| Sight Sciences, INC. | $153.25 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ani Pharmaceuticals, INC. | $144.05 | 2024-2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Novartis Pharmaceuticals Corporation | $125.78 | 2020-2023 | |
| Horizon Therapeutics Plc | $124.89 | 2021 | |
| Carl Zeiss Meditec, INC. | $121.77 | 2019 | |
| Ivantis, INC | $84.07 | 2020 | |
| Beaver-Visitec International, INC. | $83.66 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $63.45 | 2024-2025 | Xdemvy |
| Lensar, INC. | $58.03 | 2023 | Lensar Laser System |
| Kala Pharmaceuticals, INC. | $55.63 | 2021 | |
| Dompe US, INC. | $53.82 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $38.35 | 2021 | |
| Rayner Intraocular Lenses Limited | $32.50 | 2022-2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Omeros Corporation | $18.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Fair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.